Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00645428
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
W91 | 5-(3-(2,6-DICHLORO-4-(4,5-DIHYDRO- 2-OXAZOLYL)PHENOXY)PROPYL)-3-METHYL ISOXAZOLE | 1 | 2HWB | 0.77 | |
W91 | 5-(3-(2,6-DICHLORO-4-(4,5-DIHYDRO- 2-OXAZOLYL)PHENOXY)PROPYL)-3-METHYL ISOXAZOLE | 1 | 2HWD | 0.77 | |
669 | 1-(5-CARBOXYPENTYL)-5-(2,6-DICHLOROBENZYLOXY)- 1H-INDOLE-2-CARBOXYLIC ACID | A | 1MZS | 0.7 | |
IMN | INDOMETHACIN | A | 2BXM | 0.7 | |
IMN | INDOMETHACIN | A | 3FO7 | 0.7 | |
IMN | INDOMETHACIN | A,B,C,D | 1Z9H | 0.7 | |
IMN | INDOMETHACIN | A | 2BXQ | 0.7 | |
IMN | INDOMETHACIN | A,B,C,D | 4COX | 0.7 | |
IMN | INDOMETHACIN | A | 2ALT | 0.7 | |
IMN | INDOMETHACIN | A | 2OTH | 0.7 | |
IMN | INDOMETHACIN | A,B | 2DM6 | 0.7 | |
IMN | INDOMETHACIN | A | 1S2A | 0.7 | |
IMN | INDOMETHACIN | A | 2ZB8 | 0.7 | |
IMN | INDOMETHACIN | A | 3HWZ | 0.7 | |
IMN | INDOMETHACIN | A | 2BXK | 0.7 | |
ACJ | 5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]- 2-NITROBENZOIC ACID | A,B | 2IVD | 0.75 | |
W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1,4 | 1PIV | 0.71 | |
W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1,4 | 1D4M | 0.71 | |
W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2R04 | 0.71 | |
W59 | 5-(7-(5-HYDRO-4-ETHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2RS3 | 0.71 | |
W43 | 5-(7-(6-CHLORO-4-(5-HYDRO-4-METHYL- 2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE | 1 | 2RM2 | 0.77 | |
W42 | 5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO- 2-OXAZOLYL)PHENOXY)PENTYL)-3-(HYDROXYETHYL OXYMETHYLENEOXYMETHYL) ISOXAZOLE | 1 | 1R08 | 0.74 | |
643 | 6-(4-{[3-(3,5-dichloropyridin-4- yl)-5-(1-methylethyl)isoxazol-4- yl]methoxy}-2-methylphenyl)-1-methyl- 1H-indole-3-carboxylic acid | A | 3FXV | 0.71 | |
W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUE | 0.7 | |
W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 2R06 | 0.7 | |
W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUC | 0.7 | |
W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUG | 0.7 | |
O62 | 6-(4-{[3-(2,6-dichlorophenyl)-5- (1-methylethyl)isoxazol-4-yl]methoxy}phenyl)naphthalene- 1-carboxylic acid | A | 3DCU | 0.76 | |
708 | 3-[(E)-2-(2-chloro-4-{[3-{[(R)- (2,6-dichlorophenyl)(hydroxy)-lambda~4~- sulfanyl]methyl}-5-(1-methylethyl)isoxazol- 4-yl]methoxy}phenyl)ethenyl]benzoic acid | A | 3GD2 | 0.72 | |
W8R | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2RR1 | 0.71 | |
064 | 3-[(E)-2-(2-chloro-4-{[3-(2,6-dichlorophenyl)- 5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)ethenyl]benzoic acid | A | 3DCT | 0.78 | |
W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2RS1 | 0.71 | |
W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUD | 0.71 | |
W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUI | 0.71 | |
W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUH | 0.71 | |
GNI | (3-{4-[2-(2,4-DICHLORO-PHENOXY)- ETHYLCARBAMOYL]-5-PHENYL-ISOXAZOL- 3-YL}-PHENYL)-ACETIC ACID | A,B | 2J14 | 0.76 | |
W56 | 5-(5-(4-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 2RS5 | 0.7 | |
W54 | 5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO- 2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE | 1 | 2HWC | 0.77 | |
W54 | 5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO- 2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE | 1 | 2HWE | 0.77 | |
W33 | 5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2- OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE | 1 | 2R07 | 0.77 |